Schering-Plough to buy Akzo's Organon for $14.4 bln (Reuters via Yahoo! News)
Schering-Plough Corp has agreed to buy Akzo Nobel NV's drugs unit Organon BioSciences for 11 billion euros ($14.4 billion) in a bid to gain scale and diversify away from cholesterol medicine.

Organon unit to be acquired (The News & Observer)
'No cuts planned' for Organon facilities in Triangle, according to spokesman.

ICI Back in Takeover Spotlight As Akzo Builds EUR11bn War Chest (RedNova)
By Karen Attwood Shares in ICI, the UK'